Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice

Last updated: June 26, 2026
Sponsor: Seung-Jung Park
Overall Status: Active - Recruiting

Phase

N/A

Condition

Coronary Artery Disease

Atherosclerosis

Cardiac Disease

Treatment

N/A

Clinical Study ID

NCT01186133
2010-035
  • Ages > 19
  • All Genders

Study Summary

The objective of this study is to evaluate effectiveness and safety of the new drug-eluting stent (DES), as compared with the first-,second-,third-, and fourth-generation DES, in the "real world" daily practice.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • coronary disease amenable to percutaneous coronary intervention (PCI)

  • no clinical and lesion limitations

Exclusion

Exclusion Criteria:

  • patients with a mixture of several DES

  • terminal illness with life expectancy less than 1 year

  • patients with cardiogenic shock

Study Design

Total Participants: 50000
Study Start date:
January 01, 2009
Estimated Completion Date:
December 31, 2030

Study Description

Consecutive patients receiving New DES without a mixture of other DES

Connect with a study center

  • Korean centres

    Multiple Locations,
    Korea, Republic of

    Active - Recruiting

  • Korean centres

    Multiple Locations,
    South Korea

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.